Drug Profile
Smoflipid - Fresenius Kabi
Alternative Names: SmoflipidLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Fresenius Kabi
- Class Fatty acids; Lipids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Nutrition disorders